All insiders/Insider trade history
8 insider transactions across 1 company, 2026-04-09 → 2026-04-10.
Total disclosed
$5.97M
Buys
$0
Sells
$5.97M
Win rate · live
0%
Holdings
Marked using
shares-after from the latest filing × live quoteCompany
Trades
Holding value
Last trade
Avg buy / sell
% since last
BBIO
BridgeBio Pharma, Inc.
Chief Executive Officer
8
$45.72M
595.7K sh
SELL
2026-04-10
$74.61
+2.9%
Insider trade history
8 disclosed transactions
| Date | Ticker | Code | Shares | Price | Value | Now | % since |
|---|---|---|---|---|---|---|---|
| 2026-04-10 | BBIO | S↓ | 20.0K | $74.60 | $1.49M | $76.75 | +2.9% |
| 2026-04-10 | BBIO | S↓ | 20.0K | $74.60 | $1.49M | $76.75 | +2.9% |
| 2026-04-09 | BBIO | S↓ | 7.5K | $75.55 | $567K | $76.75 | +1.6% |
| 2026-04-09 | BBIO | S↓ | 7.1K | $73.64 | $521K | $76.75 | +4.2% |
| 2026-04-09 | BBIO | S↓ | 7.2K | $73.64 | $530K | $76.75 | +4.2% |
| 2026-04-09 | BBIO | S↓ | 7.8K | $75.53 | $589K | $76.75 | +1.6% |
| 2026-04-09 | BBIO | S↓ | 5.1K | $74.57 | $382K | $76.75 | +2.9% |
| 2026-04-09 | BBIO | S↓ | 5.3K | $74.60 | $395K | $76.75 | +2.9% |
Transaction codes: P open-market buy · S open-market sell · A grant/award · M option exercise · F tax withholding · G gift. % since is the move from the trade-day reported price to the live quote.
Explore related topics
- All insider tradingLive ticker of every Form 4 filed across the U.S. equity market.
- Browse all insidersFull ranked index of every officer, director, and 10%+ holder we track.
- Super investorsSee which hedge funds also hold the same companies.
- Congress stock tradesPTR disclosures from U.S. lawmakers under the STOCK Act.
- Smart-money signalsWhere insider buys, 13F flows, and Congress trades all line up.
- Daily market digestOne-page roll-up of the day's most important smart-money events.